In colon cancer cells, MAPK signaling could be hyperactive by transfection of MACC1, and HGF-induced cell scattering mediated by MACC1 could be abrogated by MEK specific inhibitors, whereas not by PI3K specific inhibitors [2]. Here, MAP2K7 is linked to colonic neoplasm.